Is Descovy really the better option? - podcast episode cover

Is Descovy really the better option?

Feb 04, 202214 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

"As individual patients, we often don’t think about these costs. In my Instagram poll, nearly everyone taking Descovy reported receiving the drug effectively for free, largely due to Gilead’s copay coupons. However, as with anything in life, nothing really ever is free. More patients taking Descovy rather than generic Truvada means higher overall spending by insurance companies. This eventually comes back to haunt us in the form of higher premiums, and is why we shouldn’t simply adopt a costlier drug like Descovy without good reason to do so."

Frank F. Zhou is a medical student.

He shares his story and discusses his KevinMD article, "Is Descovy really the better option?"

Reflect and earn 1.0 AMA PRA Category 1 CME for this episode.

For the best experience, listen in Metacast app for iOS or Android